Asahi Kasei Medical
  • Site Map
  • Contact Us
  • Font size: Small
  • Font size: Medium
  • Font size: Large
  • Home
  • Our Approach to Business
  • Corporate Information
  • News
  • Products
  • Patients and Families

August 3, 2011
Asahi Kasei Corp.
Kuraray Co., Ltd.

Corporate

Transfer of Asahi Kasei Kuraray Medical shares held by Kuraray

Asahi Kasei and Kuraray has today concluded a share transfer agreement under which Asahi Kasei will receive all the shares held by Kuraray in Asahi Kasei Kuraray Medical Co., Ltd., a joint-venture company which has been operated by the two companies since the integration of their dialyzers businesses in 2007.

Transfer of the shares

1) Shareholding ratio

Before transfer: Asahi Kasei 93%, Kuraray 7%
After transfer: Asahi Kasei 100%

2) Date of transfer:

April 1, 2012

Forthcoming managerial actions

Upon completion of the transfer of the shares held by Kuraray, Asahi Kasei Kuraray Medical Co., Ltd. will become a wholly owned subsidiary of Asahi Kasei Corp. Study on the optimal configuration to further strengthen medical devices-related operations is now to be advanced.

The company name Asahi Kasei Kuraray Medical will be changed without delay following the share transfer.

Corporate profile of Asahi Kasei Kuraray Medical

President: Yutaka Shibata
Head office: Tokyo, Japan
Paid-in capital: ¥800 million (as of March 31, 2011)
Shareholding ratio: Asahi Kasei 93%, Kuraray 7%
Business line: Production and sale of APS™ polysulfone-membrane artificial kidneys (dialyzers), Cellsorba™ leukocyte adsorption columns, and other medical devices
Production sites: Oita, Japan; and Nobeoka, Miyazaki, Japan

* This press release was issued by Asahi Kasei Corporation and Kuraray Co., Ltd.

Top of page